Nov 2020 • Blood
Carlotta Welters, Meng-Tung Hsu, Christian Alexander Stein, Livius Penter, María Fernanda Lammoglia Cobo, Kerstin Dietze, Eric Blanc, Dieter Beule, Lars Bullinger, Julian Strobel, Holger Hackstein, Armin Gerbitz, Klaus Dornmair, Thomas Blankenstein, Leo Hansmann
Multiple myeloma is a malignancy of monoclonal plasma cells accumulating in the bone marrow. The critical influence of tumor-infiltrating T cells on disease control and therapeutic responses has been shown in a variety of malignancies, however, the role of multiple myeloma bone marrow-infiltrating T cells is incompletely understood. Although it has been shown that multiple myeloma neo-antigen-specific T cells can be expanded in vitro, little is known about functions and specificities of clonally expanded multiple myeloma-infiltrating bone marrow T cells.Here we asked at the single cell level whether clonally expanded T cells i) were detectable in multiple myeloma bone marrow and peripheral blood, ii) showed characteristic immune phenotypes, and iii) recognized antigens selectively presented on multiple myeloma cells.A total of 6,744 single bone marrow T cells from 13 treatment-naïve patients were index …
Show moreNov 2020 • Blood 136, 34-35, 2020
Livius Penter, Yi Zhang, Alexandra Savell, Srinika Ranasinghe, Teddy Huang, Nicoletta Cieri, Satyen H Gohil, Wandi Zhang, Shuqiang Li, Robert Zeiser, Haesook T Kim, Kenneth J Livak, Jerome Ritz, Donna S Neuberg, Robert J Soiffer, X Shirley Liu, Matthew S Davids, Pavan Bachireddy, Catherine J Wu
Relapse after allogeneic hematopoietic stem cell transplantation (HSCT) remains an unmet medical need. The ETCTN 9204 study evaluated in 71 study subjects if immune checkpoint blockade with anti-CTLA-4 (Ipilimumab (Ipi), n = 43) or anti-PD-1 (Nivolumab (Nivo), n = 28) antibodies could stimulate graft-versus-leukemia (GvL) responses in this setting. We focused mainly on patients (pts) with relapsed AML/MDS, which constituted the majority of pts (n = 38; 54%). Ipi induced both long-term complete remissions (CR; n = 3) and transient CRs (TR; n = 3), while Nivo did not generate any CRs, but 4 patients demonstrated partial remissions (PR).To define the molecular features associated with response to Ipi, we performed bulk transcriptomic analyses of formalin-fixed paraffin-embedded biopsies of sites of AML/MDS involvement (n = 35) collected before and after Ipi treatment from 13 pts. Our analysis of matched …
Show moreNov 2020 • Blood, The Journal of the American Society of Hematology 136 (Supplement 1 …, 2020
Livius Penter, Yi Zhang, Alexandra Savell, Srinika Ranasinghe, Teddy Huang, Nicoletta Cieri, Satyen H Gohil, Wandi Zhang, Shuqiang Li, Robert Zeiser, Haesook T Kim, Kenneth J Livak, Jerome Ritz, Donna S Neuberg, Robert J Soiffer, X Shirley Liu, Matthew S Davids, Pavan Bachireddy, Catherine J Wu
Relapse after allogeneic hematopoietic stem cell transplantation (HSCT) remains an unmet medical need. The ETCTN 9204 study evaluated in 71 study subjects if immune checkpoint blockade with anti-CTLA-4 (Ipilimumab (Ipi), n = 43) or anti-PD-1 (Nivolumab (Nivo), n = 28) antibodies could stimulate graft-versus-leukemia (GvL) responses in this setting. We focused mainly on patients (pts) with relapsed AML/MDS, which constituted the majority of pts (n = 38; 54%). Ipi induced both long-term complete remissions (CR; n = 3) and transient CRs (TR; n = 3), while Nivo did not generate any CRs, but 4 patients demonstrated partial remissions (PR). To define the molecular features associated with response to Ipi, we performed bulk transcriptomic analyses of formalin-fixed paraffin-embedded biopsies of sites of AML/MDS involvement (n = 35) collected before and after Ipi treatment from 13 pts. Our analysis of …
Show moreOct 2020 • Journal of Vision
Martin Banks, Vivek Labhishetty, Steven Cholewiak
Conventional wisdom is that accommodation in humans exhibits significant errors. When the stimulus is far, the eye is thought to focus too near (“lead of accommodation”). When the stimulus is near, it focuses too far (“lag”). These errors are as large as 1 diopter, which should produce noticeably blurred imagery. But viewers typically do not experience the blur expected from such leads and lags. We re-examined this phenomenon by measuring accommodation objectively and subjectively. Objective measurements are based on measurements of light reflected off the retina. Subjective measurements are based on the viewer performing a visual task; they are more valid because they involve the whole visual process. We used a custom varifocal display apparatus to present accommodative stimuli to six young adults. On each trial, subjects fixated and focused on a Maltese cross at a distance of 0, 2, 4 or 6D. A …
Show moreOct 2020 • The EMBO Journal
Sunny Z Wu, Daniel L Roden, Chenfei Wang, Holly Holliday, Kate Harvey, Aurélie S Cazet, Kendelle J Murphy, Brooke Pereira, Ghamdan Al‐Eryani, Nenad Bartonicek, Rui Hou, James R Torpy, Simon Junankar, Chia‐Ling Chan, Chuan En Lam, Mun N Hui, Laurence Gluch, Jane Beith, Andrew Parker, Elizabeth Robbins, Davendra Segara, Cindy Mak, Caroline Cooper, Sanjay Warrier, Alistair Forrest, Joseph Powell, Sandra O'Toole, Thomas R Cox, Paul Timpson, Elgene Lim, X Shirley Liu, Alexander Swarbrick
The tumour stroma regulates nearly all stages of carcinogenesis. Stromal heterogeneity in human triple‐negative breast cancers (TNBCs) remains poorly understood, limiting the development of stromal‐targeted therapies. Single‐cell RNA sequencing of five TNBCs revealed two cancer‐associated fibroblast (CAF) and two perivascular‐like (PVL) subpopulations. CAFs clustered into two states: the first with features of myofibroblasts and the second characterised by high expression of growth factors and immunomodulatory molecules. PVL cells clustered into two states consistent with a differentiated and immature phenotype. We showed that these stromal states have distinct morphologies, spatial relationships and functional properties in regulating the extracellular matrix. Using cell signalling predictions, we provide evidence that stromal‐immune crosstalk acts via a diverse array of immunoregulatory molecules …
Show moreOct 2020 • Trends in Biochemical Sciences, 2020
Clifford A Meyer, X Shirley Liu
The Cistrome Data Browser (DB)(www. cistrome. org/db) contains a comprehensive collection of publicly available ChIP-seq, DNase-seq, and ATAC-seq profiles in human and mouse, processed using consistent workflows. Cistrome DB functions help investigators find relevant profiles and answer common questions on transcriptional or epigenetic gene regulation. Cistrome DB Toolkit functions allow users to query the database by gene, genomic interval, or set of genomic intervals.
Show moreOct 2020 • ONCOLOGY RESEARCH AND TREATMENT 43 (SUPPL 4), 239-239, 2020
Lammoglia MF Cobo, C Welters, C Pircher, R Gary, K Dietze, A Takvorian, L Penter, L Bullinger, K Dornmair, A Moosmann, J Mautner, T Blankenstein, T Kammertoens, A Gerbitz, L Hansmann
Oct 2020 • Trends in Biochemical Sciences, 2020
Clifford A Meyer, X Shirley Liu
This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.
Show moreOct 2020 • Journal of Vision
Martin Banks, Vivek Labhishetty, Steven Cholewiak
Conventional wisdom is that accommodation in humans exhibits significant errors. When the stimulus is far, the eye is thought to focus too near (“lead of accommodation”). When the stimulus is near, it focuses too far (“lag”). These errors are as large as 1 diopter, which should produce noticeably blurred imagery. But viewers typically do not experience the blur expected from such leads and lags. We re-examined this phenomenon by measuring accommodation objectively and subjectively. Objective measurements are based on measurements of light reflected off the retina. Subjective measurements are based on the viewer performing a visual task; they are more valid because they involve the whole visual process. We used a custom varifocal display apparatus to present accommodative stimuli to six young adults. On each trial, subjects fixated and focused on a Maltese cross at a distance of 0, 2, 4 or 6D. A …
Show moreSep 2020 • Nature genetics
Xihao Li, Zilin Li, Hufeng Zhou, Sheila M Gaynor, Yaowu Liu, Han Chen, Ryan Sun, Rounak Dey, Donna K Arnett, Stella Aslibekyan, Christie M Ballantyne, Lawrence F Bielak, John Blangero, Eric Boerwinkle, Donald W Bowden, Jai G Broome, Matthew P Conomos, Adolfo Correa, L Adrienne Cupples, Joanne E Curran, Barry I Freedman, Xiuqing Guo, George Hindy, Marguerite R Irvin, Sharon LR Kardia, Sekar Kathiresan, Alyna T Khan, Charles L Kooperberg, Cathy C Laurie, X Shirley Liu, Michael C Mahaney, Ani W Manichaikul, Lisa W Martin, Rasika A Mathias, Stephen T McGarvey, Braxton D Mitchell, May E Montasser, Jill E Moore, Alanna C Morrison, Jeffrey R O’Connell, Nicholette D Palmer, Akhil Pampana, Juan M Peralta, Patricia A Peyser, Bruce M Psaty, Susan Redline, Kenneth M Rice, Stephen S Rich, Jennifer A Smith, Hemant K Tiwari, Michael Y Tsai, Ramachandran S Vasan, Fei Fei Wang, Daniel E Weeks, Zhiping Weng, James G Wilson, Lisa R Yanek, Benjamin M Neale, Shamil R Sunyaev, Gonçalo R Abecasis, Jerome I Rotter, Cristen J Willer, Gina M Peloso, Pradeep Natarajan, Xihong Lin
Large-scale whole-genome sequencing studies have enabled the analysis of rare variants (RVs) associated with complex phenotypes. Commonly used RV association tests have limited scope to leverage variant functions. We propose STAAR (variant-set test for association using annotation information), a scalable and powerful RV association test method that effectively incorporates both variant categories and multiple complementary annotations using a dynamic weighting scheme. For the latter, we introduce ‘annotation principal components’, multidimensional summaries of in silico variant annotations. STAAR accounts for population structure and relatedness and is scalable for analyzing very large cohort and biobank whole-genome sequencing studies of continuous and dichotomous traits. We applied STAAR to identify RVs associated with four lipid traits in 12,316 discovery and 17,822 replication samples …
Show moreSep 2020 • Nature Medicine
Fathima Zumla Cader, Xihao Hu, Walter L Goh, Kirsty Wienand, Jing Ouyang, Elisa Mandato, Robert Redd, Lee N Lawton, Pei-Hsuan Chen, Jason L Weirather, Ron CJ Schackmann, Bo Li, Wenjiang Ma, Philippe Armand, Scott J Rodig, Donna Neuberg, X Shirley Liu, Margaret A Shipp
PD-1 blockade is highly effective in classical Hodgkin lymphomas (cHLs), which exhibit frequent copy-number gains of CD274 (PD-L1) and PDC1LG2 (PD-L2) on chromosome 9p24. 1. However, in this largely MHC-class-I-negative tumor, the mechanism of action of anti-PD-1 therapy remains undefined. We utilized the complementary approaches of T cell receptor (TCR) sequencing and cytometry by time-of-flight analysis to obtain a peripheral immune signature of responsiveness to PD-1 blockade in 56 patients treated in the CheckMate 205 phase II clinical trial (NCT02181738). Anti-PD-1 therapy was most effective in patients with a diverse baseline TCR repertoire and an associated expansion of singleton clones during treatment. CD4+, but not CD8+, TCR diversity significantly increased during therapy, most strikingly in patients who had achieved complete responses. Additionally, patients who responded to …
Show moreSep 2020 • Nature cell biology
Yang Gao, Naoe Taira Nihira, Xia Bu, Chen Chu, Jinfang Zhang, Aleksandra Kolodziejczyk, Yizeng Fan, Ngai Ting Chan, Leina Ma, Jing Liu, Dong Wang, Xiaoming Dai, Huadong Liu, Masaya Ono, Akira Nakanishi, Hiroyuki Inuzuka, Brian J North, Yu-Han Huang, Samanta Sharma, Yan Geng, Wei Xu, X Shirley Liu, Lei Li, Yoshio Miki, Piotr Sicinski, Gordon J Freeman, Wenyi Wei
Immunotherapies that target programmed cell death protein 1 (PD-1) and its ligand PD-L1 as well as cytotoxic T-lymphocyte-associated protein 4 (CTLA4) have shown impressive clinical outcomes for multiple tumours. However, only a subset of patients achieves durable responses, suggesting that the mechanisms of the immune checkpoint pathways are not completely understood. Here, we report that PD-L1 translocates from the plasma membrane into the nucleus through interactions with components of the endocytosis and nucleocytoplasmic transport pathways, regulated by p300-mediated acetylation and HDAC2-dependent deacetylation of PD-L1. Moreover, PD-L1 deficiency leads to compromised expression of multiple immune-response-related genes. Genetically or pharmacologically modulating PD-L1 acetylation blocks its nuclear translocation, reprograms the expression of immune-response-related …
Show moreJul 2020 • Nature 583 (7818), 693-698, 2020
Michael P Snyder, Thomas R Gingeras, Jill E Moore, Zhiping Weng, Mark B Gerstein, Bing Ren, Ross C Hardison, John A Stamatoyannopoulos, Brenton R Graveley, Elise A Feingold, Michael J Pazin, Michael Pagan, Daniel A Gilchrist, Benjamin C Hitz, J Michael Cherry, Bradley E Bernstein, Eric M Mendenhall, Daniel R Zerbino, Adam Frankish, Paul Flicek, Richard M Myers
The Encylopedia of DNA Elements (ENCODE) Project launched in 2003 with the long-term goal of developing a comprehensive map of functional elements in the human genome. These included genes, biochemical regions associated with gene regulation (for example, transcription factor binding sites, open chromatin, and histone marks) and transcript isoforms. The marks serve as sites for candidate cis-regulatory elements (cCREs) that may serve functional roles in regulating gene expression 1. The project has been extended to model organisms, particularly the mouse. In the third phase of ENCODE, nearly a million and more than 300,000 cCRE annotations have been generated for human and mouse, respectively, and these have provided a valuable resource for the scientific community.
Show moreJul 2020 • Nature
Jill E Moore, Michael J Purcaro, Henry E Pratt, Charles B Epstein, Noam Shoresh, Jessika Adrian, Trupti Kawli, Carrie A Davis, Alexander Dobin, Rajinder Kaul, Jessica Halow, Eric L Van Nostrand, Peter Freese, David U Gorkin, Yin Shen, Yupeng He, Mark Mackiewicz, Florencia Pauli-Behn, Brian A Williams, Ali Mortazavi, Cheryl A Keller, Xiao-Ou Zhang, Shaimae I Elhajjajy, Jack Huey, Diane E Dickel, Valentina Snetkova, Xintao Wei, Xiaofeng Wang, Juan Carlos Rivera-Mulia, Joel Rozowsky, Jing Zhang, Surya B Chhetri, Jialing Zhang, Alec Victorsen, Kevin P White, Axel Visel, Gene W Yeo, Christopher B Burge, Eric Lécuyer, David M Gilbert, Job Dekker, John Rinn, Eric M Mendenhall, Joseph R Ecker, Manolis Kellis, Robert J Klein, William S Noble, Anshul Kundaje, Roderic Guigó, Peggy J Farnham, J Michael Cherry, Richard M Myers, Bing Ren, Brenton R Graveley, Mark B Gerstein, Len A Pennacchio, Michael P Snyder, Bradley E Bernstein, Barbara Wold, Ross C Hardison, Thomas R Gingeras, John A Stamatoyannopoulos, Zhiping Weng
The human and mouse genomes contain instructions that specify RNAs and proteins and govern the timing, magnitude, and cellular context of their production. To better delineate these elements, phase III of the Encyclopedia of DNA Elements (ENCODE) Project has expanded analysis of the cell and tissue repertoires of RNA transcription, chromatin structure and modification, DNA methylation, chromatin looping, and occupancy by transcription factors and RNA-binding proteins. Here we summarize these efforts, which have produced 5,992 new experimental datasets, including systematic determinations across mouse fetal development. All data are available through the ENCODE data portal (https://www. encodeproject. org), including phase II ENCODE 1 and Roadmap Epigenomics 2 data. We have developed a registry of 926,535 human and 339,815 mouse candidate cis-regulatory elements, covering 7.9 and 3 …
Show moreJul 2020 • Nucleic acids research
Taiwen Li, Jingxin Fu, Zexian Zeng, David Cohen, Jing Li, Qianming Chen, Bo Li, X Shirley Liu
Tumor progression and the efficacy of immunotherapy are strongly influenced by the composition and abundance of immune cells in the tumor microenvironment. Due to the limitations of direct measurement methods, computational algorithms are often used to infer immune cell composition from bulk tumor transcriptome profiles. These estimated tumor immune infiltrate populations have been associated with genomic and transcriptomic changes in the tumors, providing insight into tumor–immune interactions. However, such investigations on large-scale public data remain challenging. To lower the barriers for the analysis of complex tumor–immune interactions, we significantly improved our previous web platform TIMER. Instead of just using one algorithm, TIMER2.0 (http://timer.cistrome.org/) provides more robust estimation of immune infiltration levels for The Cancer Genome Atlas (TCGA) or user-provided …
Show moreJul 2020 • Nature Communications
Jing Zhang, Donghoon Lee, Vineet Dhiman, Peng Jiang, Jie Xu, Patrick McGillivray, Hongbo Yang, Jason Liu, William Meyerson, Declan Clarke, Mengting Gu, Shantao Li, Shaoke Lou, Jinrui Xu, Lucas Lochovsky, Matthew Ung, Lijia Ma, Shan Yu, Qin Cao, Arif Harmanci, Koon-Kiu Yan, Anurag Sethi, Gamze Gürsoy, Michael Rutenberg Schoenberg, Joel Rozowsky, Jonathan Warrell, Prashant Emani, Yucheng T Yang, Timur Galeev, Xiangmeng Kong, Shuang Liu, Xiaotong Li, Jayanth Krishnan, Yanlin Feng, Juan Carlos Rivera-Mulia, Jessica Adrian, James R Broach, Michael Bolt, Jennifer Moran, Dominic Fitzgerald, Vishnu Dileep, Tingting Liu, Shenglin Mei, Takayo Sasaki, Claudia Trevilla-Garcia, Su Wang, Yanli Wang, Chongzhi Zang, Daifeng Wang, Robert J Klein, Michael Snyder, David M Gilbert, Kevin Yip, Chao Cheng, Feng Yue, X Shirley Liu, Kevin P White, Mark Gerstein
ENCODE comprises thousands of functional genomics datasets, and the encyclopedia covers hundreds of cell types, providing a universal annotation for genome interpretation. However, for particular applications, it may be advantageous to use a customized annotation. Here, we develop such a custom annotation by leveraging advanced assays, such as eCLIP, Hi-C, and whole-genome STARR-seq on a number of data-rich ENCODE cell types. A key aspect of this annotation is comprehensive and experimentally derived networks of both transcription factors and RNA-binding proteins (TFs and RBPs). Cancer, a disease of system-wide dysregulation, is an ideal application for such a network-based annotation. Specifically, for cancer-associated cell types, we put regulators into hierarchies and measure their network change (rewiring) during oncogenesis. We also extensively survey TF-RBP crosstalk, highlighting …
Show moreJun 2020 • Investigative Ophthalmology & Visual Science
Vivek Labhishetty, Steven A Cholewiak, Martin S Banks
Purpose: Typically, objective measurement of accommodation using autorefractors, photorefractors or aberrometers reveals response lags and leads implying that the eye does not focus precisely at the distance of the object of regard. These errors are thought to be due to the eye’s depth of focus. Because of the depth of focus an out-of-focus image is perceived as acceptably sharp. We examined these response errors by comparing objective and subjective measures of best focus.Methods: Accommodative stimuli were presented to six healthy adults (20-35 years) using a varifocal display system. Changes in accommodation and pupil size were recorded using a wavefront sensor. On each trial, subjects first fixated a Maltese cross at a distance of 0, 2, 4 or 6D and were told to try to maintain image sharpness. After the 3-sec presentation of the cross, we measured visual acuity with a briefly presented tumbling E …
Show moreApr 2020 • The Journal of Clinical Investigation 130 (4), 1595-1607, 2020
Livius Penter, Catherine J Wu
Hematological malignancies have long been at the forefront of the development of novel immune-based treatment strategies. The earliest successful efforts originated from the extensive body of work in the field of allogeneic hematopoietic stem cell transplantation. These efforts laid the foundation for the recent exciting era of cancer immunotherapy, which includes immune checkpoint blockade, personal neoantigen vaccines, and adoptive T cell transfer. At the heart of the specificity of these novel strategies is the recognition of target antigens presented by malignant cells to T cells. Here, we review the advances in systematic identification of minor histocompatibility antigens and neoantigens arising from personal somatic alterations or recurrent driver mutations. These exciting efforts pave the path for the implementation of personalized combinatorial cancer therapy.
Show moreFeb 2020 • Adaptive Optics and Wavefront Control for Biological Systems VI 11248, 57-63, 2020
Gordon D Love, Martin S Banks, Steven A Cholewiak, Abigail P Finch
In optics in general, a sharp aberration-free image is normally the desired goal, and the whole field of adaptive optics has developed with the aim of producing blur-free images. Likewise, in ophthalmic optics we normally aim for a sharp image on the retina. But even with an emmetropic, or well-corrected eye, chromatic and high order aberrations affect the image. We describe two different areas where it is important to take these effects into account and why creating blur correctly via rendering can be advantageous. Firstly we show how rendering chromatic aberration correctly can drive accommodation in the eye and secondly report on matching defocus-l generated using rendering with conventional optical defocus.
Show moreJan 2020 • Cancer Research
Changxin Wan, Matthew P Keany, Han Dong, Linah F Al-Alem, Unnati M Pandya, Suzan Lazo, Karsten Boehnke, Katherine N Lynch, Rui Xu, Dominique T Zarrella, Shengqing Gu, Paloma Cejas, Klothilda Lim, Henry W Long, Kevin M Elias, Neil S Horowitz, Colleen M Feltmate, Michael G Muto, Michael J Worley, Ross S Berkowitz, Ursula A Matulonis, Marisa R Nucci, Christopher P Crum, Bo R Rueda, Myles Brown, Xiaole Shirley Liu, Sarah J Hill
Immune therapies have had limited efficacy in high-grade serous ovarian cancer (HGSC), as the cellular targets and mechanism(s) of action of these agents in HGSC are unknown. Here we performed immune functional and single-cell RNA sequencing transcriptional profiling on novel HGSC organoid/immune cell co-cultures treated with a unique bispecific anti-programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) antibody compared with monospecific anti-PD-1 or anti-PD-L1 controls. Comparing the functions of these agents across all immune cell types in real time identified key immune checkpoint blockade (ICB) targets that have eluded currently available monospecific therapies. The bispecific antibody induced superior cellular state changes in both T and natural killer (NK) cells. It uniquely induced NK cells to transition from inert to more active and cytotoxic phenotypes …
Show moreJan 2020 • Clinical Cancer Research
Sailing Shi, Shengqing Gu, Tong Han, Wubing Zhang, Lei Huang, Ziyi Li, Deng Pan, Jingxin Fu, Jun Ge, Myles Brown, Peng Zhang, Peng Jiang, Kai W Wucherpfennig, Xiaole Shirley Liu